You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hemoglobinopathies

Showing 1 - 25 of 138
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Hemoglobinopathies and Bone Health

Active, not recruiting
  • Sickle Cell Disease
  • Sickle Cell Trait
  • Healthy volunteers without SCT
  • +2 more
  • Farmington, Connecticut
    UConn Health
Nov 1, 2022

Study of the Role of Genetic Modifiers in Hemoglobinopathies

Recruiting
  • Sickle Cell Disease
  • +3 more
  • GWAS
  • Boston, Massachusetts
  • +24 more
Apr 4, 2023

Alpha Thalassemia Hemoglobin H Constant Spring, Hemoglobinopathies, Hereditary Diseases Trial in Nanning (RM-004)

Recruiting
  • Alpha Thalassemia Hemoglobin H Constant Spring
  • +2 more
  • RM-004
  • Nanning, Guangxi, China
    The 923rd Hospital of Joint Logistics Support Force of People's
Oct 25, 2023

Hemoglobinopathies, Thalassemia, Sickle Cell Disease Trial in Banha (Hemoglobinopathy Nursing Program)

Completed
  • Hemoglobinopathies
  • +3 more
  • Hemoglobinopathy Nursing Program
  • Banhā, Other, Egypt
    Benha University
May 21, 2022

Hemoglobinopathies and Rare Inherited Anemia and Covid 19

Recruiting
  • Haemoglobinopathies
    • Genova, Italy
    • +1 more
    May 4, 2022

    Screening for Hemoglobinopathies in Pregnant Women

    Recruiting
    • Hemoglobinopathies
    • Review of routine lab data
    • Basel, Switzerland
      Frauenklinik University Hospital Basel
    Oct 13, 2021

    Total Splenectomy vs Partial Splenectomy in Non-malignant

    Not yet recruiting
    • Splenectomy; Status
      • Montpellier, France
        University hospital of Montpellier
      Dec 22, 2021

      Alpha Thalassemia Major, Hemoglobinopathy; With Thalassemia, Hemoglobinopathies Trial in San Francisco (in utero hematopoietic

      Enrolling by invitation
      • Alpha Thalassemia Major
      • +8 more
      • in utero hematopoietic stem cell transplantation
      • San Francisco, California
        University of California
      Oct 28, 2022

      Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)

      Recruiting
      • Beta-Thalassemia
      • +4 more
      • CTX001
      • Nashville, Tennessee
      • +5 more
      Feb 2, 2023

      Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance Trial in Nashville (CTX001)

      Recruiting
      • Sickle Cell Disease
      • +4 more
      • CTX001
      • Philadelphia, Pennsylvania
      • +3 more
      Jan 24, 2023

      Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)

      Recruiting
      • Transfusion Dependent Beta Thalassemia
      • +3 more
      • EDIT-301
      • Oakland, California
      • +3 more
      Jan 3, 2023

      Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate

      Recruiting
      • Non Malignant Diseases
      • +2 more
      • RIC: Distal Campath
      • +2 more
      • Philadelphia, Pennsylvania
        The Children's Hospital of Philadelphia
      Mar 8, 2022

      Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)

      Active, not recruiting
      • Sickle Cell Disease
      • Hemoglobinopathies
      • Nashville, Tennessee
        Vanderbilt-Ingram Cancer Center
      Dec 20, 2021

      Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

      Not yet recruiting
      • Beta-Thalassemia
      • +6 more
      • CTX001
      • (no location specified)
      Jul 26, 2022

      Women With Heterozygous Hemoglobinopathies

      Completed
      • Heterozygous Haemoglobinopathy
      • pregnancy outcome
      • Basel, Switzerland
      • +1 more
      Jun 30, 2021

      Oxidative Stress and Iron Overload in Abnormal Haemoglobinopathy

      Not yet recruiting
      • Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System
        • (no location specified)
        Oct 16, 2022

        STUDY INCIDENCE AND CHARACTERISTICS OF MALIGNANT NEOPLASIES IN

        Recruiting
        • Malignacy, Hemoglobinopathie
          • Cagliari, Italy
            Azienda Ospedaliera Universitaria Di Cagliari
          Mar 18, 2022

          AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

          Recruiting
          • AML
          • +8 more
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          May 13, 2022

          Sickle Cell Disease, Beta Thalassemia-Major Trial in New Hyde Park (alemtuzumab (Campath IH), Fludarabine, Melphalan)

          Completed
          Has Results
          • Sickle Cell Disease
          • Beta Thalassemia-Major
          • alemtuzumab (Campath IH)
          • +6 more
          • New Hyde Park, New York
            Cohen Children's Medical Center of New York
          Jul 30, 2021

          Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

          Not yet recruiting
          • Acute Lymphoblastic Leukemia in Remission
          • +10 more
          • CliniMACS
          • Houston, Texas
          • +1 more
          Dec 8, 2022

          Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem

          Active, not recruiting
          • Hematologic Malignancies
          • +7 more
          • San Francisco, California
            University of California, San Francisco
          Feb 28, 2022

          Hemoglobinopathies Trial (transcranial doppler)

          Not yet recruiting
          • Hemoglobinopathies
          • transcranial doppler
          • (no location specified)
          Mar 12, 2021

          Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

          Recruiting
          • Sickle Cell Disease
          • +4 more
          • Duarte, California
            City of Hope Medical Center
          Jul 6, 2022

          Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)

          Active, not recruiting
          • Beta-Thalassemia
          • +4 more
          • CTX001
          • Stanford, California
          • +11 more
          Nov 30, 2022

          Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,

          Recruiting
          • Severe Sickle Cell Disease
          • +5 more
          • RIC regimen
          • GVHD prophylaxis regimen
          • New Haven, Connecticut
          • +1 more
          Feb 4, 2022